Modulation of Neural Spiking in Motor Cortex–Cerebellar Networks during Sleep Spindles
Pierson Fleischer,
No information about this author
Aamir Abbasi,
No information about this author
Tanuj Gulati
No information about this author
et al.
eNeuro,
Journal Year:
2024,
Volume and Issue:
11(5), P. ENEURO.0150 - 23.2024
Published: April 19, 2024
Sleep
spindles
appear
to
play
an
important
role
in
learning
new
motor
skills.
Motor
skill
engages
several
brain
regions
with
two
areas
being
the
cortex
(M1)
and
cerebellum
(CB).
However,
neurophysiological
processes
these
during
sleep,
especially
how
spindle
oscillations
affect
local
cross-region
spiking,
are
not
fully
understood.
We
recorded
activity
from
M1
cerebellar
eight
rats
spontaneous
investigate
sleep
related
spiking
as
well
spiking.
found
that
firing
was
significantly
changed
both
CB
spindles,
this
occurred
at
a
preferred
phase
of
spindle.
On
average,
neurons
showed
most
or
peaks.
These
also
developed
preferential
locking
cross-area
greatest
phase-locking
value
peaks;
however,
significant
for
when
compared
spindles.
Additionally,
we
percentage
task-modulated
cells
fired
nonuniform
spike
distribution
M1/CB
peaks
were
greater
learned
reach-to-grasp
task
robustly.
Finally,
band
LFP
coherence
(for
LFPs)
positive
correlation
success
rate
task.
findings
support
idea
recruit
participate
awake
memory
consolidation.
Language: Английский
A variant of the autophagic receptor NDP52 counteracts phospho-TAU accumulation and emerges as a protective factor for Alzheimer Disease
Anna Mattioni,
No information about this author
Claudia Carsetti,
No information about this author
Krenare Bruqi
No information about this author
et al.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 14, 2024
ABSTRACT
Selective
elimination
of
early
pathological
TAU
species
may
be
a
promising
therapeutic
strategy
to
reduce
accumulation
that
contributes
neurodegeneration
and
hallmarks
Alzheimer
disease
(AD).
By
performing
genetic
analysis
cohort
435
patients
with
AD,
we
defined
the
NDP52
GE
variant
(rs550510)
autophagic
receptor
(also
known
as
CALCOCO2)
protective
factor
for
AD.
We
provide
evidence
in
vitro
systems
Drosophila
melanogaster
model
TAU-induced
reduces
forms
through
process
rescues
typical
neurodegenerative
phenotypes
induced
by
hTAU-toxicity.
More
importantly,
showed
is
much
more
effective
this
respect
than
WT
.
Mechanistically,
directly
binds
phospho-TAU,
bind
them
comparable
efficiency.
On
contrary,
machinery
(LC3C
LC3B)
efficiently
also
first
time
direct
target
protein
phosphatase
2A
(PP2A)
,
opening
way
possibility
fine-tune
function
Finally,
found
positive
correlation
between
worldwide
distribution
allele
encoding
incidence
or
prevalence
Overall,
our
work
highlights
resilience
AD
shows
robust
effectiveness
drive
degradation.
Language: Английский
Long-term motor and cognitive outcome of Deep Brain Stimulation in GBA-PD: the Italian PARKNET study
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 28, 2024
Abstract
Deep
brain
stimulation
(DBS)
is
an
established
therapeutic
option
for
Parkinson
Disease
(PD),
with
demonstrated
efficacy
on
motor
symptoms
also
in
patients
carrying
GBA1
variants
(GBA-PD).
However,
it
was
recently
suggested
that
DBS
may
accelerate
cognitive
decline
this
frequent
genetic
subgroup,
raising
major
concerns
its
indication.
Primary
aim
of
study
to
investigate
the
possible
additive
effects
genotype
and
implant
deterioration
other
non-motor
features
long
term.
As
secondary
aims,
we
assessed
clinical
outcomes
DBS-GBA-PD
stratified
by
variant
classes
(severe/complex,
mild,
risk,
unknown),
different
targets
(subthalamic
nucleus
or
globus
pallidus).
This
a
multicenter
retrospective,
controlled,
Italian
cohort
involving
15
tertiary
level
Movement
Disorder
Centers
contributing
PARKNET
cohort.
Demographic,
motor,
were
collected
at
baseline
after
1,
3
5
years,
between
years
2005
2021.
We
selected
615
PD
participants
who
either
underwent
surgery
(430
DBS-nonGBA-PD
109
DBS-GBA-PD)
fulfilled
same
criteria
eligibility
but
eventually
not
operated
(76
nonDBS-GBA-PD).
Assessments
included
features,
as
well
long-term
complications,
across
all
groups
time
points.
Within-group
longitudinal
outcome
changes,
between-group
differences,
subgroups
analyses
performed.
At
baseline,
three
cohorts
largely
matched
demographic,
features.
Longitudinally,
both
showed
marked
improvements
quality
life,
benefit
which
absent
nonDBS-GBA-PD.
Cognitive
deterioration,
hallucinations
urinary
problems,
significantly
increased
GBA-PD
compared
nonGBA-PD,
regardless
DBS.
No
relevant
differences
emerged
upon
stratification
targets,
up
surgery.
represents
valid
GBA-PD,
generates
prolonged
benefits
life
while
modifying
occurrence
Language: Английский